In all cases, loss of BAX conferred no substantial protection against these cytotoxic drugs compared to control cells, showing that loss of BAX is not a general resistance factor in these Eμ-Myc lymphoma cells, but confers specific resistance to S63845. This evidence concerns the gene BAX and lymphoma.